|
|
||||||||
AJP - Endocrinology and Metabolism, Vol 270, Issue 5 E882-E889, Copyright © 1996 by American Physiological Society
ARTICLES |
D. Yang, S. F. Previs, C. A. Fernandez, S. Dugelay, M. V. Soloviev, J. W. Hazey, K. C. Agarwal, W. C. Levine, F. David, P. Rinaldo, M. Beylot and H. Brunengraber
Department of Nutrition, Case Western Reserve University, Cleveland, Ohio 44106, USA.
In human and primate liver, phenylacetate and glutamine form phenylacetylglutamine, which is excreted in urine. Probing noninvasively the labeling pattern of liver citric acid cycle intermediates with phenylacetylglutamine assumes that the labeling pattern of its glutamine moiety reflects that of liver alpha-ketoglutarate. To validate this probe, we infused monkeys with [U-13C3]lactate, [3-13C]lactate, [1, 2-13C2]acetate, [2-13C]acetate, [U-13C3]glycerol, or 2-[3-13C]ketoisocaproate and compared the labeling patterns of urinary phenylacetyl-glutamine with those of glutamate and glutamine in liver, plasma, muscle, and kidney and liver alpha-ketoglutarate. Only with [U-13C3]lactate or [3-13C]lactate does the labeling pattern of phenylacetylglutamine reflect patterns of liver alpha-ketoglutarate and glutamate. With [13C]acetate, muscle and kidney glutamate are more labeled than liver metabolites. This confirms that with [13C]acetate, the labeling pattern of liver metabolites is influenced by 13CO2 and [13C]glutamine made in peripheral tissues. Our data validate the use of phenylacetylglutamine labeled from [3-13C]lactate or [3-13C]pyruvate to probe noninvasively the pyruvate carboxylase-to-pyruvate dehydrogenase flux ratio in human subjects.
This article has been cited by other articles:
![]() |
A. Conjard, S. Dugelay, M.-F. Chauvin, D. Durozard, G. Baverel, and G. Martin The Anaplerotic Substrate Alanine Stimulates Acetate Incorporation into Glutamate and Glutamine in Rabbit Kidney Tubules. A 13C NMR STUDY J. Biol. Chem., August 9, 2002; 277(33): 29444 - 29454. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Yang and H. Brunengraber Glutamate, a Window on Liver Intermediary Metabolism J. Nutr., April 1, 2000; 130(4): 991 - 991. [Abstract] [Full Text] |
||||
![]() |
F. Diraison, V. Large, C. Maugeais, M. Krempf, and M. Beylot Noninvasive tracing of human liver metabolism: comparison of phenylacetate and apoB-100 to sample glutamine Am J Physiol Endocrinol Metab, September 1, 1999; 277(3): E529 - E536. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Jones, M. A. Solomon, A. D. Sherry, F. M. H. Jeffrey, and C. R. Malloy 13C NMR measurements of human gluconeogenic fluxes after ingestion of [U-13C]propionate, phenylacetate, and acetaminophen Am J Physiol Endocrinol Metab, November 1, 1998; 275(5): E843 - E852. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |